Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

Completed · Phase 3 · Has a placebo group

Conditions studied: Hypoalbuminemia, Protein-energy Malnutrition, Inflammation, Oxidative Stress, Chronic Kidney Disease (CKD) Hemodialysis

In brief

Study of efficiency and safety of oral nutritional supplements with anti-inflammatory and antioxidative properties combined with an appetite stimulant with anti-inflammatory properties (pentoxiphylline) in treatment of malnutrition-inflammation-cachexia syndrome in maintenance hemodialysis patients

Key facts

Study ID
NCT00561093
Run by
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
People needed
93
Starts
2008-02-01
Expected to finish
2011-05-01
Last updated by the study team
2015-05-21

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.